Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:1763-1765

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soubrier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soubrier, F.

(Circulation. 1998;97:1763-1765.)
© 1998 American Heart Association, Inc.


Editorial

Blood Pressure Gene at the Angiotensin I–Converting Enzyme Locus

Chronicle of a Gene Foretold

Florent Soubrier, MD, PhD

From INSERM U358, Hôpital Saint-Louis, Paris, France.

Correspondence to Florent Soubrier, INSERM U358, Hôpital Saint-Louis, 1 av Claude Vellefaux, 75475 Paris cedex 10, and Laboratoire de Génétique Moléculaire, Hôpital Tenon, 4, rue de la Chine, 75970 Paris cedex 20, France. E-mail florent.soubrier@tnn.ap-hop-paris.fr


Key Words: Editorials • chromosomes • pseudohypoaldosteronism • linkage disequilibrium • genetics

The candidate gene approach allows several genes responsible for several monogenic forms of hypertension to be identified, owing to an accurate knowledge of the clinical and biological phenotypes of these diseases, to the judicious choice of candidate genes whose functions are tightly related to the phenotypes, and to the mendelian segregation of these diseases in large pedigrees.1 However, in humans, no gene has been definitively established as a source of genetic variance of BP, corresponding to the putative major gene suggested by some segregation analyses2 3 or as a predisposing gene to hypertension. Even if some data indicate a possible role for the angiotensinogen (AGT) gene and if associations are found with other genes, conflicting results are found in the literature, and no clear physiological effect on BP has been associated with a functional variant. In the rat model of hereditary hypertension, although >10 loci linked to BP have been identified in various strains, no single gene has yet been identified.

In this issue, two articles report data suggesting a linkage between the ACE locus and DBP or mean BP.4 5 In both studies, several hundred families were studied, and these were not selected for a particular level of BP but were chosen to represent large samples of the population. The statistical methodology used to quantify, by a family approach, the effect of the ACE locus on BP is slightly different in the two studies. The study by O'Donnell et al4 used a classic approach through the use of the SIBPAL . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HypertensionHome page
G. D.M. Marques, B. M.R. Quinto, F. L. Plavinik, J. E. Krieger, O. Marson, and D. E. Casarini
N-Domain Angiotensin I-Converting Enzyme With 80 kDa as a Possible Genetic Marker of Hypertension
Hypertension, October 1, 2003; 42(4): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Kammerer, D. L. Rainwater, J. L. Schneider, L. A. Cox, M. C. Mahaney, J. Rogers, and J. F. VandeBerg
Two Loci Affect Angiotensin I-Converting Enzyme Activity in Baboons
Hypertension, March 1, 2003; 41(3): 854 - 859.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. R. Dengel, M. D. Brown, R. E. Ferrell, T. H. Reynolds IV, and M. A. Supiano
Exercise-induced changes in insulin action are associated with ACE gene polymorphisms in older adults
Physiol Genomics, October 29, 2002; 11(2): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. C. Luft
Molecular Genetics of Salt-Sensitivity and Hypertension
Drug Metab. Dispos., April 1, 2001; 29(4): 500 - 504.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. S. Cooper, X. Guo, C. N. Rotimi, A. Luke, R. Ward, A. Adeyemo, and S. M. Danilov
Heritability of Angiotensin-Converting Enzyme and Angiotensinogen : A Comparison of US Blacks and Nigerians
Hypertension, May 1, 2000; 35(5): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Wang, M. J. Katovich, C. H. Gelband, P. Y. Reaves, M. I. Phillips, and M. K. Raizada
Sustained Inhibition of Angiotensin I-Converting Enzyme (ACE) Expression and Long-Term Antihypertensive Action by Virally Mediated Delivery of ACE Antisense cDNA
Circ. Res., October 1, 1999; 85(7): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. T. Turner, E. Boerwinkle, and C. F. Sing
Context-Dependent Associations of the ACE I/D Polymorphism With Blood Pressure
Hypertension, October 1, 1999; 34(4): 773 - 778.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Kato, T. Sugiyama, H. Morita, T. Nabika, H. Kurihara, Y. Yamori, and Y. Yazaki
Lack of Evidence for Association Between the Endothelial Nitric Oxide Synthase Gene and Hypertension
Hypertension, April 1, 1999; 33(4): 933 - 936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Krushkal, R. Ferrell, S. C. Mockrin, S. T. Turner, C. F. Sing, and E. Boerwinkle
Genome-Wide Linkage Analyses of Systolic Blood Pressure Using Highly Discordant Siblings
Circulation, March 23, 1999; 99(11): 1407 - 1410.
[Abstract] [Full Text] [PDF]